News und Analysen

Day One Biopharmaceuticals (NASDAQ:DAWN), a clinical-stage biopharmaceutical company focused on developing therapies for pediatric cancers and rare tumor types, reported its earnings for Q2 2025 on

Rhythm Pharmaceuticals (NASDAQ:RYTM), a biopharmaceutical company focused on rare genetic diseases related to obesity, reported its Q2 2025 earnings on August 5, 2025. However, the company reported

Wall Street is always on the lookout for the next big thing, and quantum computing is one of this year's hottest topics. Look no further than IonQ (NYSE: IONQ), which has surged roughly 500% over

Growth stocks have made a strong comeback after a rocky start to the year, driven by anticipated deregulation and significant breakthroughs in artificial intelligence (AI). Valuations have surged

The best way to build your wealth is to park your money in solid growth stocks and hold them over the long term. By doing so, you enjoy steady capital appreciation as these promising stocks churn

Crushing beats on both the top and bottom lines by Bombardier Recreational Products (NASDAQ: DOOO), or BRP, clearly impressed the stock market on Thursday. Buoyed by highly encouraging results from

The company formerly known as Square but changed its name to Block (NYSE: XYZ) is one of the more interesting companies you'll come across. It was a market darling during the COVID-19 pandemic

Economic worries, prompted by ongoing uncertainty about how tariff announcements will ultimately play out, are scaring investors. The benchmark S&P 500 index has lost 8% of its value in 2025 (as of